Newsroom

Sorted by: Latest

-

UDR, Inc. Announces Appointment of Scott McCallum as Executive Vice President – Chief Investment Officer

DENVER--(BUSINESS WIRE)--UDR, Inc. (the “Company”) (NYSE: UDR), a leading multifamily real estate investment trust, today announced that Scott McCallum will join the Company as Executive Vice President - Chief Investment Officer (“EVP-CIO”), effective November 5, 2026. He will report to Thomas W. Toomey, Chairman, President, and Chief Executive Officer of UDR. Mr. McCallum will bring an extensive background in public and private real estate with a decade of experience in real estate investments...
-

KKR Real Estate Finance Trust Inc. to Announce Third Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) announced today that it plans to release its financial results for the third quarter 2026 on Wednesday, October 28, 2026, after the close of trading on the New York Stock Exchange. A conference call to discuss KREF’s financial results will be held on Thursday, October 29, 2026 at 11:00 a.m. ET. The conference call may be accessed by dialing (800) 715-9871 (U.S. callers) or (646) 307-1963 (non-U.S. callers toll);...
-

Don Templin Elected to Jackson’s Board of Directors

LANSING, Mich.--(BUSINESS WIRE)--Jackson Financial Inc.i (NYSE: JXN) (Jackson®) announced today that its Board of Directors has elected Donald C. (“Don”) Templin as a new independent director. He was also appointed as a member of the Board’s Audit and Compensation committees. “I am pleased to welcome Don to Jackson’s Board of Directors,” said Steve Kandarian, independent chair of the Jackson board. “His experience as a financial leader in the insurance and energy industries, combined with his e...
-

Equity Bancshares, Inc. Third Quarter Results Highlighted by Organic Loan Growth and Announced Merger with Lincoln Bancorp

WICHITA, Kan.--(BUSINESS WIRE)--Equity Bancshares, Inc. (NYSE: EQBK) (“Equity”, “the Company,” “we,” “us,” “our”), the Wichita-based holding company of Equity Bank, reported net income of $26.8 million or $1.29 per diluted share for the quarter ended September 30, 2026. Core earnings per diluted share for the quarter was $1.40. “This quarter our company continued to execute at an exciting level. Earnings were strong, production reached all-time highs and loans grew organically. We are putting t...
-

StubHub Announces Extension of Senior Credit Facilities

NEW YORK--(BUSINESS WIRE)--StubHub Holdings, Inc. (NYSE: STUB), a leading global ticketing marketplace for live events, today announced it has extended the maturities of its senior credit facilities, further strengthening the company’s balance sheet and extending its capital structure runway. StubHub, through its wholly owned subsidiary StubHub Holdco Sub, LLC, amended its existing credit agreement to extend the maturity of its $804 million USD Term Loan B and its €452 million Euro Term Loan B...
-

Primerica Schedules Third Quarter 2026 Financial Results Webcast

DULUTH, Ga.--(BUSINESS WIRE)--Primerica Schedules Third Quarter 2026 Financial Results Webcast...
-

EnerSys Appoints Navi Grewal as Chief Digital, AI and Information Officer

READING, Pa.--(BUSINESS WIRE)--EnerSys (NYSE: ENS), a global leader in stored energy solutions for industrial, infrastructure, and defense applications, today announced the appointment of Navi Grewal as Chief Digital, AI and Information Officer, effective October 16, 2026. Ms. Grewal will report to Shawn O’Connell, President and Chief Executive Officer, and will serve as a member of the EnerSys Executive Leadership Team. In this role, Ms. Grewal will lead EnerSys’ global digital, artificial int...
-

Celanese Corporation Declares Quarterly Dividend of $0.03 Per Share

DALLAS--(BUSINESS WIRE)--Celanese Corporation Declares Quarterly Dividend of $0.03 Per Share...
-

Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing CD19- and CD22-targeted ARTEMIS® T-cell therapies to treat cancers and autoimmune diseases, today announced the activation of a fifth clinical site for its ongoing STARLIGHT-1 Phase I/II clinical trial evaluating its investigational product candidate EB103, a CD19-Redirected ARTEMIS® T-cell therapy, in patients with relapsed o...
-

Surge Components, Inc. Announces Third Quarter 2026 Results

DEER PARK, N.Y.--(BUSINESS WIRE)--Surge Components, Inc. (“Surge” or the “Company”) (OTC Pink: SPRS), a leading supplier of capacitors, discrete semi-conductors, switches, and audible/sounding devices, today announced financial results for the third fiscal quarter ended August 31, 2026. Operational Highlights Expands global commercial reach across Europe and Asia Continues to invest in growth including the hiring of new engineering talent Financial Highlights for the Third Quarter Ended August...